It is cervical cancer awareness prevention week in the UK. Did you know that Ingress-health is strongly focused on conducting
ABQ-HIV: a unique questionnaire for identifying potential risk factors associated with medication related non-adherence for HIV-patients
Non-adherence to medication is
Meet us at ISPOR Europe 2018, in Barcelona (10-14 November)!
That time of the year has come again, when the
Ingress-health ISPOR contributions
On November 10-14, the vibrant city of Barcelona, Spain, will host the annual ISPOR Europe Conference.
In its latest publication, using the example of COPD (paper available here), a team of Ingress-health real-world evidence experts explored whether
Ingress-health has conducted a multi-center patient preference study addressing atrial fibrillation patients’ preferences for their oral anticoagulation treatment. The results
The Spanish office will be lead by Pablo Rebollo. Pablo has over 20 years of experience in Spanish market access
We are happy to share with you our latest publication on time-to-event outcomes in patients with nonmetastatic castration-resistant prostate cancer
Ingress Health is a young, dynamic health economics and outcomes research consultancy.
Our mission is to find the unexplored value
The poster “Real-world treatment persistence and associated costs with biologic therapy in patients with Inflammatory Bowel Disease (IBD): Results of